Comparison of ERA-923, a new selective estrogen receptor modulator (SERM) for the treatment of estrogen-receptor positive breast cancer, with other SERMs.

被引：0
|
作者：
Greenberger, LM
Komm, B
Miller, C
Annable, T
Lyttle, R
Frost, P
机构：
[1] Wyeth Ayerst Res, Pearl River, NY USA
[2] Wyeth Ayerst Res, Radnor, PA USA
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
491
引用
收藏
页码：4565S / 4565S
页数：1
相关论文
共 50 条
  • [41] EVIDENCE THAT PREMENOPAUSAL AND PERI-MENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR NEGATIVE, PROGESTERONE-RECEPTOR POSITIVE BREAST-CANCER HAVE ESTROGEN-RECEPTOR
    SARRIF, AM
    DURANT, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 138 - 138
  • [42] Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist
    Olayoku, Folasade R. R.
    Verhoog, Nicolette J. D.
    Louw, Ann
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [43] Evaluating Progesterone Receptor (PgR) Status as a Prognostic Indicator in Estrogen-receptor Positive Breast Cancer
    Folan, P. J.
    O'Halloran, N.
    Ryan, E. J.
    Kerin, M. J.
    Lowery, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (SUPPL 12) : S359 - S359
  • [44] Development of cardiac events in postmenopausal breast cancer patients treated with Aromatase inhibitor (AI) and Selective estrogen receptor modulator (SERM).
    Parajuli, Priyanka
    Regmi, Manjari Rani
    Maini, Ruby
    Garcia, Odalys Estefania Lara
    Tandan, Nitin
    Mirihagalle, Noupama
    Cheema, Asad
    Abedrabo, Sabree
    Niaz, Zurain
    Koester, Cameron
    Sahib, Hamsa
    Bhandari, Bishal
    Johnson, Alexander
    Ibrahim, Abdisamad M.
    Delfino, Kristin
    Robinson, Kathy
    Desai, Meghna R.
    Kulkarni, Abhishek
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] IMMUNOHISTOCHEMICAL QUANTITATION OF ESTROGEN-RECEPTORS AND PROLIFERATIVE ACTIVITY IN ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER
    JENSEN, V
    LADEKARL, M
    JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (05) : 429 - 432
  • [46] MicroRNA 29 family restores estrogen receptor and selective estrogen receptors regulators (SERMs) sensitivity in breast cancer.
    Fabbri, Muller
    Adair, Brett
    Wernicke, Dorothee
    Garzon, Ramiro
    Valeri, Nicola
    Cimmino, Amelia
    Zanesi, Nicola
    Croce, Carlo
    CANCER RESEARCH, 2009, 69
  • [47] Gene expression profiles with activation of the estrogen receptor α-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor
    Levenson, AS
    Svoboda, KM
    Pease, KM
    Kaiser, SA
    Chen, B
    Simons, LA
    Jovanovic, BD
    Dyck, PA
    Jordan, VC
    CANCER RESEARCH, 2002, 62 (15) : 4419 - 4426
  • [48] Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis
    Kung, Annie W. C.
    Chu, Eva Y. W.
    Xu, Ling
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (08) : 1377 - 1385
  • [49] Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer
    Yutaka Yamamoto
    Hirotaka Iwase
    International Journal of Clinical Oncology, 2008, 13 : 384 - 394
  • [50] Lasofoxifene: A new type of selective estrogen receptor modulator for the treatment of osteoporosis
    Gennari, Luigi
    DRUGS OF TODAY, 2006, 42 (06) : 355 - 367
12345